Skinvisible (SKVI) Price to FCF (2010 - 2026)
Skinvisible's (SKVI) quarterly Price to FCF came in at 525.13 in Q2 2026, up 430.73% year-over-year from 98.95 in Q2 2025, and up 133.28% quarter-over-quarter from 1577.76 in Q1 2026.
Analysis
Skinvisible (SKVI) Price to FCF (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Price to FCF across 17 years of filings, most recently posting 525.13 for Q2 2026.
- In Q2 2026, Price to FCF rose 430.73% year-over-year to 525.13; the TTM figure through Jun 2026 stood at 295.6 (up 1525.55% YoY), while the FY2025 annual figure was 29.25, down 27.9% from the prior year.
- Price to FCF came in at 525.13 for Q2 2026 at Skinvisible, up from 1577.76 in the prior quarter.
- In the past five years, Price to FCF ranged from a high of 1543.96 in Q3 2025 to a low of 1577.76 in Q1 2026.
- Average Price to FCF over 5 years is 7.57, with a median of 24.65 recorded in 2022.
- Year-over-year, Price to FCF jumped 760.02% in 2025 and sank 1496.78% in 2026.
- Over 5 years, Price to FCF stood at 9.86 in 2022, then plunged by 858.31% to 94.51 in 2023, then retreated by 13.1% to 106.89 in 2024, then jumped by 688.74% to 629.31 in 2025, then dropped by 16.55% to 525.13 in 2026.
- Per Business Quant data, the three most recent Price to FCF figures were 525.13 in Q2 2026, 1577.76 in Q1 2026, and 629.31 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.78 Bn | 626.02 Bn | 17.26 Bn |
| 2 | AbbVie | 439.42 Bn | 432.85 Bn | 12.70 Bn |
| 3 | Merck | 364.63 Bn | 357.49 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.84 Bn | 261.15 Bn | 11.24 Bn |
| 5 | Pfizer | 158.75 Bn | 147.05 Bn | 10.94 Bn |
| 6 | Sanofi | 52.62 Bn | 45.24 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - |
| 8 | Incyte | 24.99 Bn | 20.45 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.13 Bn | 18.47 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 525.13 |
| Mar 31, 2026 | -1,577.76 |
| Dec 31, 2025 | 629.31 |
| Sep 30, 2025 | 1,543.96 |
| Jun 30, 2025 | -158.78 |
| Mar 31, 2025 | -98.81 |
| Dec 31, 2024 | -106.89 |
| Sep 30, 2024 | -233.93 |
| Jun 30, 2024 | -130.56 |
| Mar 31, 2024 | -25.86 |
| Dec 31, 2023 | -94.51 |
| Sep 30, 2023 | -65.97 |
| Jun 30, 2023 | -17.74 |
| Mar 31, 2023 | -6.95 |
| Dec 31, 2022 | -9.86 |
| Sep 30, 2022 | -23.44 |
| Jun 30, 2022 | 3.31 |
| Mar 31, 2022 | -14.42 |
| Dec 31, 2021 | 7.08 |
| Sep 30, 2021 | 10.04 |